NIH-funded research R01 grant

PFAS exposure and kidney disease risk in teens with type 2 diabetes

Official title: PFAS Exposure and Diabetic Kidney Disease in Youth with Type 2 Diabetes: A Multi-Omic Approach for Prevention and Treatment

Funded at University of Southern California · NIH-11370697 · Data updated 2026-11-12

Aging and kidney health study in youths with type 2 diabetes to see how a common chemical (PFAS) affects kidney risk and how to prevent or treat it.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Southern California
NIH-funded
Lab location1 site (Los Angeles, UNITED STATES)
Project startSeptember 10, 2024
Project endJune 30, 2029
Funding year2026
Award (this year)$684,007
NIH project number5R01DK140831-03
Project IDNIH-11370697 on NIH RePORTER

Who could benefit from this research

Could help

Youth aged 12-20 with type 2 diabetes, especially those from Hispanic or African American backgrounds.

Less likely to help

Teens without type 2 diabetes or those not exposed to PFAS may not benefit.

What this research studies

This project follows teens and young adults with type 2 diabetes to understand how exposure to PFAS chemicals may worsen kidney health. It uses existing groups of participants and detailed measurements to link PFAS in the body with kidney injury in the proximal tubules. The team will explore whether reducing reabsorption of PFAS in kidney tubules could lower DKD risk, aiming to identify practical prevention or treatment strategies. The study builds on strong preliminary data and collaborates with diverse youth cohorts to ensure findings are relevant to understudied populations.

Why it matters

Potential benefit: If successful, this work could lead to new ways to prevent or lessen diabetic kidney disease in youths with type 2 diabetes by addressing PFAS exposure and tubular kidney processes.

How similar studies have gone: Previous observations suggest PFAS can affect kidney cells, but this is a pioneering, focused study in youth with type 2 diabetes.

Where this research is happening

  • University of Southern California
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Goodrich, Jesse Allen — University of Southern California
  • Study coordinator: Goodrich, Jesse Allen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.